← Back to Search

Behavioural Intervention

Early Intervention for Language Delay

N/A
Recruiting
Led By Karla N Washington, PhD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Child is between 18 and 30 months of age
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 1 or 2 (pre/time 1); weeks 9 or 10 (post/time 2), weeks 17 or 18 (followup/time 3)
Awards & highlights

Study Summary

This trial seeks to use neuroscience and behavior to better understand late talking and how to treat it. Early intervention can help mitigate effects.

Who is the study for?
This trial is for children aged 18-30 months who are late talkers and primarily English-speaking without vision issues. They must be enrolled at a participating facility, have no MRI contraindications like metal implants or claustrophobia, and not be in special education due to ability or behavior.Check my eligibility
What is being tested?
The study aims to understand the brain and behavioral aspects of late talking in toddlers using neuroimaging techniques and behavioral assessments. It seeks to identify memory-language mechanisms that could inform tailored interventions for language development disorders.See study design
What are the potential side effects?
There are generally no direct side effects from the non-invasive procedures used in this study such as neuroimaging (MRI) scans. However, there might be discomfort or anxiety related to lying still during imaging, but these can typically be managed with breaks and reassurance.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is between 18 and 30 months old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 1 or 2 (pre/time 1); weeks 9 or 10 (post/time 2), weeks 17 or 18 (followup/time 3)
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 1 or 2 (pre/time 1); weeks 9 or 10 (post/time 2), weeks 17 or 18 (followup/time 3) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Aim 1/Pre - Structural connectivity data using diffusion imaging
Aim 2/Pre - Changes in structural connectivity data using diffusion imaging
Secondary outcome measures
Aim 1 - Raw score on the Focus on the Outcomes of Communication Under Six Parent Version- (second set)
Aim 1/Pre - Raw score calculated using a Consonant Inventory- (sixth set)
Aim 1/Pre - Raw score calculated using a Play-based language sample- (seventh set)
+15 more
Other outcome measures
Aim 1/Pre - qualitative data clinician reported
Aim 1/Pre - qualitative data parent reported
Aim 2 - Qualitative data parent reported
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention to address late talkingExperimental Treatment1 Intervention
half the participants receive an intervention program addressing late talking. The intervention is comprised of adult learning (to teach parents) and direct support for children who are late talkers. The intervention occurs over 6 to 8 weeks and is designed to improve grammar, vocabulary, and functional communication
Group II: Waitlist controlsActive Control1 Intervention
half the participants are waitlist controls who receive intervention at a later date, after the study has ended

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
690 Previous Clinical Trials
1,019,598 Total Patients Enrolled
1 Trials studying Language Developmental Disorders
184 Patients Enrolled for Language Developmental Disorders
Holland Bloorview Kids Rehabilitation HospitalOTHER
67 Previous Clinical Trials
14,029 Total Patients Enrolled
Children's Hospital Medical Center, CincinnatiOTHER
815 Previous Clinical Trials
6,531,546 Total Patients Enrolled
1 Trials studying Language Developmental Disorders
184 Patients Enrolled for Language Developmental Disorders

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are seniors excluded from this trial or can they participate?

"As specified in the prerequisites for enrollment, children must fall between 18-30 months of age to be eligible."

Answered by AI

Who can volunteer for this medical experiment?

"Patients suffering from language delay between 18 and 30 months of age can be admitted to this study. 45 participants are required for the trial's completion."

Answered by AI

How many participants are taking part in this research?

"Affirmative. Clinicaltrials.gov data demonstrates that this clinical trial, which was initially published on December 1st 2023, is actively sourcing applicants. 45 participants must be recruited from 2 distinct medical centres."

Answered by AI

Are there any remaining vacancies for volunteers in this experiment?

"Affirmative. The online repository of clinical trials, clinicaltrials.gov, supports the fact that this medical study is actively recruiting participants and has been since December 1st 2023. 45 volunteers are being sought out from two distinct locations."

Answered by AI

What is the primary goal of this investigation?

"The primary objective of this trial, measured between Weeks 1 and 2 (Time 1/pre), is to observe changes in structural connectivity data using diffusion imaging. Secondary goals include assessing the raw score on the Focus on the Outcomes of Communication Under Six Clinician Version- (third set) from 45 clinicians across all participants with a minimum possible score of 0 and maximum 238; gauging the raw score for Intelligibility in Context Scale- (fourth set) collected from each participant's parents, ranging from 0 to 35; as well as monitoring changes in MacArthur Bates Communicative Development Inventories: Words and Sentences- (first set)"

Answered by AI
~9 spots leftby May 2024